AU2895392A - Transdermal therapeutic systems containing crystallization inhibitors - Google Patents

Transdermal therapeutic systems containing crystallization inhibitors

Info

Publication number
AU2895392A
AU2895392A AU28953/92A AU2895392A AU2895392A AU 2895392 A AU2895392 A AU 2895392A AU 28953/92 A AU28953/92 A AU 28953/92A AU 2895392 A AU2895392 A AU 2895392A AU 2895392 A AU2895392 A AU 2895392A
Authority
AU
Australia
Prior art keywords
transdermal therapeutic
systems containing
therapeutic systems
crystallization inhibitors
containing crystallization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28953/92A
Inventor
Ralph Lipp
Jutta Riedl
Johannes Tack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2895392A publication Critical patent/AU2895392A/en
Priority to AU16529/97A priority Critical patent/AU712692B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Abstract

Described is a transdermal therapeutic system which is characterized in that it includes a crystallization inhibitor, and optionally also penetration enhancers, in an adhesive matrix containing the active substance.
AU28953/92A 1991-10-31 1992-10-21 Transdermal therapeutic systems containing crystallization inhibitors Abandoned AU2895392A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU16529/97A AU712692B2 (en) 1991-10-31 1997-03-25 Transdermal therapeutic systems containing crystallization inhibitors

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4136057 1991-10-31
DE4210711 1992-03-27
DE4210711A DE4210711A1 (en) 1991-10-31 1992-03-27 TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU16529/97A Division AU712692B2 (en) 1991-10-31 1997-03-25 Transdermal therapeutic systems containing crystallization inhibitors

Publications (1)

Publication Number Publication Date
AU2895392A true AU2895392A (en) 1993-06-07

Family

ID=25908725

Family Applications (2)

Application Number Title Priority Date Filing Date
AU28953/92A Abandoned AU2895392A (en) 1991-10-31 1992-10-21 Transdermal therapeutic systems containing crystallization inhibitors
AU16529/97A Expired AU712692B2 (en) 1991-10-31 1997-03-25 Transdermal therapeutic systems containing crystallization inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU16529/97A Expired AU712692B2 (en) 1991-10-31 1997-03-25 Transdermal therapeutic systems containing crystallization inhibitors

Country Status (14)

Country Link
EP (1) EP0610357B1 (en)
JP (1) JP3526864B2 (en)
AT (1) ATE158181T1 (en)
AU (2) AU2895392A (en)
CA (1) CA2120599C (en)
DE (2) DE4210711A1 (en)
DK (1) DK0610357T3 (en)
ES (1) ES2106888T3 (en)
FI (1) FI110061B (en)
GR (1) GR3025237T3 (en)
HU (1) HU227531B1 (en)
NO (1) NO307644B1 (en)
PT (1) PT101019B (en)
WO (1) WO1993008795A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5919478A (en) * 1993-06-25 1999-07-06 Alza Corporation Incorporating poly-N-vinyl amide in a transdermal system
DE4333595A1 (en) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermal therapeutic system for applying drugs to the skin
DE4405899A1 (en) * 1994-02-18 1995-08-24 Schering Ag Agent for transdermal application containing desogestrel
DE4429667C2 (en) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol TTS with water-binding additives and process for its preparation
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Compositions for transdermal delivery of acid-labile drugs
DE19500662C2 (en) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Plaster containing estradiol and its use
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
WO1996040355A1 (en) † 1995-06-07 1996-12-19 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (en) * 1996-07-11 1998-01-15 Schering Ag Transdermal therapeutic systems
DE19649535C2 (en) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Process for the production of a plaster-shaped therapeutic system
DE19701949A1 (en) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermal therapeutic system
GB9720470D0 (en) * 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (en) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
DE19829713C1 (en) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutic system with the addition of pearlescent pigments
DE19834006A1 (en) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiol-containing patch for the transdermal application of hormones
DE19843027A1 (en) * 1998-09-19 2000-03-23 Labtec Gmbh Transdermal therapeutic system used for administration of sex hormones contains neohesperidin dihydrochalcone to inhibit crystallization of active agent
DE10012908B4 (en) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilized supersaturated transdermal therapeutic matrix systems and methods for their preparation
DE10033853A1 (en) * 2000-07-12 2002-01-31 Hexal Ag Transdermal therapeutic system, containing highly dispersed silicon dioxide in matrix or adhesive layer to promote drug permeation through the skin
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
JP4914826B2 (en) 2005-02-28 2012-04-11 久光製薬株式会社 Transdermal absorption preparation
JP5537412B2 (en) * 2008-02-27 2014-07-02 久光製薬株式会社 Patch preparation
EP2255802B1 (en) 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
JP5618822B2 (en) 2008-03-03 2014-11-05 久光製薬株式会社 Transdermal absorption preparation
DE102010040299A1 (en) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
ES2958185T3 (en) * 2013-09-11 2024-02-05 Medrx Co Ltd New composition for dressing base material in a tape preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (en) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts OSTROGEN-ACTIVE PLASTER
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (en) * 1990-04-06 1995-12-13 積水化学工業株式会社 Nitroglycerin patch

Also Published As

Publication number Publication date
NO307644B1 (en) 2000-05-08
GR3025237T3 (en) 1998-02-27
ES2106888T3 (en) 1997-11-16
HU227531B1 (en) 2011-07-28
ATE158181T1 (en) 1997-10-15
HUT72964A (en) 1996-06-28
HU9401257D0 (en) 1994-08-29
WO1993008795A1 (en) 1993-05-13
EP0610357B1 (en) 1997-09-17
NO941593D0 (en) 1994-04-29
FI942011A (en) 1994-04-29
DE59208918D1 (en) 1997-10-23
FI942011A0 (en) 1994-04-29
AU1652997A (en) 1997-05-29
CA2120599A1 (en) 1993-05-13
CA2120599C (en) 2003-04-15
JP3526864B2 (en) 2004-05-17
DK0610357T3 (en) 1998-05-11
FI110061B (en) 2002-11-29
PT101019A (en) 1994-02-28
EP0610357A1 (en) 1994-08-17
AU712692B2 (en) 1999-11-11
DE4210711A1 (en) 1993-05-06
NO941593L (en) 1994-04-29
JPH07506083A (en) 1995-07-06
PT101019B (en) 1999-10-29

Similar Documents

Publication Publication Date Title
AU1652997A (en) Transdermal therapeutic systems containing crystallization inhibitors
AU2229892A (en) Transdermal therapeutic systems
BR9609794A (en) Transdermal therapeutic system (stt)
AR009516A1 (en) A PRESSURE SENSITIVE ADHESIVE MATRIX PATCH DEVICE, A METHOD FOR PREPARING SUCH A DEVICE AND A METHOD FOR USING SUCH DEVICE IN THE TRANSDERMIC SUPPLY OF A DRUG.
DE69426988T2 (en) TRANSDERMAL DELIVERY DEVICE
DE69829961D1 (en) TRANSDERMAL DEVICE FOR THE ADMINISTRATION OF TESTOSTERONE
AU5498296A (en) Transdermally administrable medicament with ACE inhibitors
AU679450B2 (en) Transdermal therapeutic system containing the active substance 17-beta -oestradiol (anhydrous)
ZA9510234B (en) Pharmaceutical preparation with an active loratidine metabolite
AU4015097A (en) Transdermal therapeutic system having an active compound combination comprising oestriol